Blog
RSS FeedPosted by Michael Wonder on 27 Sep 2019
Industry shoots down Labour's plans to tackle 'extortionate' drug prices
26 September 2019 - Labour's promise to “take on pharmaceutical companies” which “deny life-saving and life-changing medicines to ill patients ...
Posted by Michael Wonder on 24 Sep 2019
Drug firms admit to colluding in order to keep prices up
20 September 2019 - Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up. ...
Posted by Michael Wonder on 14 Aug 2019
Drug company Aspen may pay NHS £8 million after investigation alleges illegal deal to hike drug price
14 August 2019 - The drug company Aspen may have to pay the NHS £8 million (€8.7 million ; $9.7 ...
Posted by Michael Wonder on 13 May 2019
The UK’s new medicines pricing deal – opportunities and risks for pharma
10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access ...
Posted by Michael Wonder on 18 Mar 2019
CMA drops anti-competitive case against MSD
18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...
Posted by Michael Wonder on 21 Jan 2019
NHS England sees off AbbVie's hepatitis C legal challenge
21 January 2019 - Claims of unfair process dismissed by High Court. ...
Posted by Michael Wonder on 21 Jan 2019
New agreement on branded drugs for the NHS
18 January 2019 - The new Voluntary Scheme for Branded Medicines Pricing and Access began on 1 January and was ...
Posted by Michael Wonder on 16 Jan 2019
The UK’s new five year pricing agreement
16 January 2019 - Pharma has agreed to capped growth again – in exchange for uptake promises. ...
Posted by Michael Wonder on 27 Nov 2018
Pharma agrees to 2 percent cap on branded meds growth
25 November 2018 - The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price ...
Posted by Michael Wonder on 05 Oct 2018
MHRA consults on new regulatory framework for ‘no-deal’ scenario
5 October 2018 - The Medicines and Healthcare products Regulatory Agency has launched a consultation seeking views on how its ...
Posted by Michael Wonder on 14 Sep 2018
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...
Posted by Michael Wonder on 11 Sep 2018
ABPI hits out at ‘punitive’ UK medicines cost controls
11 September 2018 - Steep rise in charges an 'alarming signal' amid Brexit uncertainty ...
Posted by Michael Wonder on 08 Aug 2018
UK unveils plans for bigger medicines price squeeze
7 August 2018 - Company payments to government would rise steeply to 2021. ...
Posted by Michael Wonder on 07 Aug 2018
Government looks to include biosimilars in price controls
7 August 2018 - The government has launched consultation on proposed changes to the statutory scheme for pharmaceutical pricing that ...
Posted by Michael Wonder on 07 Jun 2018
Pfizer wins appeal against £84m UK fine over epilepsy drug price
7 June 2018 - Tribunal finds competition watchdog was wrong in its market dominance conclusions. ...